Stockreport

Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Acceptable [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF The overall pay is comparable to the industry average Over the past three years, Revolution Medicines' EPS fell by 19% and over the past three years, the total shareh [Read more]